ResearcherNebraska Medical CenterActive in the last 2 years
Geoffrey A. Talmon
Matched on ORCID iD 0000-0002-4841-286X; OpenAlex author ID A5052717470. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 62
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 4 papers · 2021: 2 papers · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 14
- SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117387↗
- Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. Co-author DOI 10.1038/s41388-026-03896-5↗
- MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16203439↗
- Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling. Co-author DOI 10.1016/j.ebiom.2021.103772↗
- Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.2c00203↗
- Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-022-02493-6↗
- Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2020.11.029↗
- MASTL regulates EGFR signaling to impact pancreatic cancer progression. Co-author DOI 10.1038/s41388-021-01951-x↗
- Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Co-author DOI 10.1016/j.bbcan.2019.188318↗
- Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-20-0033↗
- Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective. First author DOI 10.46883/onc.3406.0196↗
- Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging. Co-author DOI 10.7150/thno.40688↗
- Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Co-author DOI 10.1053/j.gastro.2018.05.041↗
- Pancreatic Polypeptide Cell Proliferation in the Pancreas and Duodenum Coexisting in a Patient With Pancreatic Adenocarcinoma Treated With a GLP-1 Analog. Co-author DOI 10.1097/mpa.0000000000000844↗
Closest collaborators
The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 8 shared papers, 2018–2026 · strength 1.09
- Paper SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. DOI 10.1016/j.celrep.2026.117387↗
- Paper Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. DOI 10.1038/s41388-026-03896-5↗
- Paper Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer. DOI 10.1016/j.jconrel.2020.11.029↗
- Moorthy Palanimuthu Ponnusamy · 7 shared papers, 2018–2026 · strength 0.99
- Paper SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. DOI 10.1016/j.celrep.2026.117387↗
- Paper Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. DOI 10.1038/s41388-026-03896-5↗
- Paper Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer. DOI 10.1016/j.jconrel.2020.11.029↗
- Sanchita Rauth · 5 shared papers, 2018–2026 · strength 0.74
- Paper SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. DOI 10.1016/j.celrep.2026.117387↗
- Paper Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. DOI 10.1038/s41388-026-03896-5↗
- Paper MASTL regulates EGFR signaling to impact pancreatic cancer progression. DOI 10.1038/s41388-021-01951-x↗
- Michael Anthony Hollingsworth · 4 shared papers, 2020–2026 · strength 0.61
- Paper Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. DOI 10.1038/s41388-026-03896-5↗
- Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
- Paper Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging. DOI 10.7150/thno.40688↗
- Aaron M. Mohs · 4 shared papers, 2020–2024 · strength 0.61
- Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
- Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
- Paper Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging. DOI 10.7150/thno.40688↗
- Satyanarayana Rachagani · 5 shared papers, 2018–2022 · strength 0.54
- Paper Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer. DOI 10.1016/j.jconrel.2020.11.029↗
- Paper MASTL regulates EGFR signaling to impact pancreatic cancer progression. DOI 10.1038/s41388-021-01951-x↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Madeline T. Olson · 3 shared papers, 2020–2024 · strength 0.49
- Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
- Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
- Paper Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic C… DOI 10.1158/1535-7163.mct-20-0033↗
- Venkatesh Varadharaj · 2 shared papers, 2026 · strength 0.45
- Nivedeta Krishna Kumar · 2 shared papers, 2026 · strength 0.45
- Kirtana Arikath · 2 shared papers, 2026 · strength 0.45
- Palanisamy Nallasamy · 2 shared papers, 2026 · strength 0.45
- Jesse L. Cox · 2 shared papers, 2026 · strength 0.45
- Zahraa Wajih Alsafwani · 2 shared papers, 2026 · strength 0.45
- Parthasarathy Seshacharyulu · 4 shared papers, 2018–2022 · strength 0.42
- Paper Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer. DOI 10.1016/j.jconrel.2020.11.029↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Lynette M. Smith · 4 shared papers, 2018–2022 · strength 0.40
- Paper MASTL regulates EGFR signaling to impact pancreatic cancer progression. DOI 10.1038/s41388-021-01951-x↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Pranita Atri · 4 shared papers, 2018–2022 · strength 0.38
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Paper Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). DOI 10.1016/j.bbcan.2019.188318↗
- Kathryn M. Muilenburg · 2 shared papers, 2022–2024 · strength 0.37
- Mark A. Carlson · 2 shared papers, 2022–2024 · strength 0.37
- Ashu Shah · 2 shared papers, 2022–2026 · strength 0.34
- Saravanakumar Marimuthu · 2 shared papers, 2022–2026 · strength 0.33
- Paper Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. DOI 10.1038/s41388-026-03896-5↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Kavita B. Mallya · 2 shared papers, 2022–2026 · strength 0.33
- Paper Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. DOI 10.1038/s41388-026-03896-5↗
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Jean L. Grem · 2 shared papers, 2022–2026 · strength 0.33
- Paper Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. DOI 10.1038/s41388-026-03896-5↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Maneesh Jain · 3 shared papers, 2020–2022 · strength 0.32
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Paper Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). DOI 10.1016/j.bbcan.2019.188318↗
- Rama Krishna Nimmakayala · 3 shared papers, 2018–2022 · strength 0.28
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
- Paper Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. DOI 10.1053/j.gastro.2018.05.041↗
- Sanjib Chaudhary · 2 shared papers, 2022 · strength 0.22
- Paper Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in panc… DOI 10.1038/s41388-022-02493-6↗
- Paper Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and im… DOI 10.1016/j.ebiom.2021.103772↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.